{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:41:27Z","timestamp":1782254487604,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12020-021-02868-x","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T11:21:43Z","timestamp":1632223303000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-8588","authenticated-orcid":false,"given":"Lucilla D.","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo Bechi","family":"Genzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Galluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spadoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Magistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piermarco","family":"Piatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"2868_CR1","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","volume":"32","author":"G Reaven","year":"2012","unstructured":"G. Reaven, Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb. Vasc. Biol. 32, 1754\u20139 (2012). https:\/\/doi.org\/10.1161\/ATVBAHA.111.241885","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2868_CR2","doi-asserted-by":"publisher","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","volume":"7","author":"KB Gast","year":"2012","unstructured":"K.B. Gast, N. Tjeerdema, T. Stijnen, J.W. Smit, O.M. Dekkers, Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 7, e52036 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0052036","journal-title":"PLoS ONE"},{"key":"2868_CR3","first-page":"3740","volume":"85","author":"M Stumvoll","year":"2000","unstructured":"M. Stumvoll, S. Jacob, H.G. Wahl, B. Hauer, K. Loblein, P. Grauer, R. Becker, M. Nielsen, W. Renn, H. haring, Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in human. J. Clin. Endocrinol. Metab. 85, 3740\u20133745 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2868_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA","volume":"128","author":"S Zhao","year":"2021","unstructured":"S. Zhao, C.M. Kusminski, P.E. Scherer, Adiponectin, leptin and cardiovascular disorders. Circ. Res 128, 136\u2013149 (2021). https:\/\/doi.org\/10.1161\/CIRCRESAHA","journal-title":"Circ. Res"},{"key":"2868_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/BF03346639","volume":"33","author":"J Zaletel","year":"2010","unstructured":"J. Zaletel, D.P. Barlovic, J. Prezelj, Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes. J. Endocrinol. Invest 33, 514\u20138 (2010). https:\/\/doi.org\/10.1007\/BF03346639","journal-title":"J. Endocrinol. Invest"},{"key":"2868_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.metabol.2006.05.010","volume":"55","author":"M Inoue","year":"2006","unstructured":"M. Inoue, M. Yano, M. Yamakado, Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 55, 1248\u201354 (2006). https:\/\/doi.org\/10.1016\/j.metabol.2006.05.010","journal-title":"Metabolism"},{"key":"2868_CR7","doi-asserted-by":"publisher","first-page":"e017470","DOI":"10.1161\/JAHA.120.017470","volume":"10","author":"P Finneran","year":"2021","unstructured":"P. Finneran, A. Pampana, S.A. Khetarpal, M. Trinder, A.P. Patel, K. Paruchuri, K. Aragam, G.M. Peloso, P. Natarajan, Lipoprotein (a) and coronary artery disease risk without a family history of heart disease. J. Am. Heart Assoc. 10, e017470 (2021). https:\/\/doi.org\/10.1161\/JAHA.120.017470","journal-title":"J. Am. Heart Assoc."},{"key":"2868_CR8","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"B.G. Nordestgaard, M.J. Chapman, K. Ray, J. Bor\u00e9n, F. Andreotti, G.F. Watts et al. European Atherosclerosis Society Consensus Panel. Lipoprotein (a) as a cardiovascular risk factor: current status. Eur. Heart J. 31, 2844\u201353 (2010). https:\/\/doi.org\/10.1093\/eurheartj\/ehq386","journal-title":"Eur. Heart J."},{"key":"2868_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Emerging Risk Factors Collaboration, S. Erqou, S. Kaptoge, P.L. Perry, E. Di Angelantonio, A. Thompson, I.R. White et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302, 412\u201323 (2009). https:\/\/doi.org\/10.1001\/jama.2009.1063","journal-title":"JAMA"},{"key":"2868_CR10","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"R. Clarke, J.F. Peden, J.C. Hopewell, T. Kyriakou, A. Goel, S.C. Heath et al. PROCARDIS Consortium. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N. Engl. J. Med. 361, 2518\u201328 (2009). https:\/\/doi.org\/10.1056\/NEJMoa0902604","journal-title":"N. Engl. J. Med."},{"key":"2868_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2337\/dc19-0274","volume":"42","author":"JL Jin","year":"2019","unstructured":"J.L. Jin, Y.X. Cao, H.W. Zhang, D. Sun, Q. Hua, Y.F. Li et al. Lipoprotein(a) and Cardiovascular Outcomes in Coronary Artery Disease in patients with prediabetes and diabetes. Diabetes Care 42, 1312\u20138 (2019). https:\/\/doi.org\/10.2337\/dc19-0274","journal-title":"Diabetes Care"},{"key":"2868_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-0952-2","volume":"21","author":"R Huang","year":"2020","unstructured":"R. Huang, S.-R. Zhao, Y. Li, F. Liu, Y. Gong, J. Xing, Z.-S. Xu, Association of tumor necrosis factor-\u03b1 gene polymorphisms and coronary artery disease susceptibility: a systematic review and meta-analysis. BMC Med. Genet. 21, 29 (2020). https:\/\/doi.org\/10.1186\/s12881-020-0952-2","journal-title":"BMC Med. Genet."},{"key":"2868_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jcb.21080","volume":"100","author":"D Gupta","year":"2007","unstructured":"D. Gupta, S. Varma, R.L. Khandelwal, Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt\/PKB. J. Cell Biochem 100, 593\u2013607 (2007). https:\/\/doi.org\/10.1002\/jcb.21080","journal-title":"J. Cell Biochem"},{"key":"2868_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep18093","volume":"5","author":"H Zhao","year":"2015","unstructured":"H. Zhao, X. Huang, J. Jiao, H. Zhang, J. Liu, W. Qin et al. Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-\u03b1-induced hepatic insulin resistance. Sci. Rep. 5, 18093 (2015). https:\/\/doi.org\/10.1038\/srep18093","journal-title":"Sci. Rep."},{"key":"2868_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2017","unstructured":"M.S.H. Akash, K. Rehman, A. Liaqat, Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J. Cell Biochem 119, 105\u201310 (2017). https:\/\/doi.org\/10.1002\/jcb.26174","journal-title":"J. Cell Biochem"},{"key":"2868_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"K.G. Alberti, P. Zimmet, J. Shaw; IDF epidemiology task force consensus group, The metabolic syndrome\u2013a new worldwide definition. Lancet 366, 1059\u201362 (2005). https:\/\/doi.org\/10.1016\/S0140-6736(05)67402-8","journal-title":"Lancet"},{"key":"2868_CR17","first-page":"1","volume":"3","author":"TD Topolski","year":"2006","unstructured":"T.D. Topolski, J. LoGerfo, D.L. Patrick, B. Williams, J. Walwick, M.B. Patrick, The rapid assessment of physical activity (RAPA) among older adults. Prev. Chronic Dis. 3, 1\u20138 (2006)","journal-title":"Prev. Chronic Dis."},{"key":"2868_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00125-010-1966-7","volume":"54","author":"J Vangipurapu","year":"2011","unstructured":"J. Vangipurapu, A. Stan\u010d\u00e1kov\u00e1, T. Kuulasmaa, J. Paananen, J. Kuusisto, E. Ferrannini et al. A novel surrogate index for hepatic insulin resistance. Diabetologia 54, 540\u20133 (2011). https:\/\/doi.org\/10.1007\/s00125-010-1966-7. & the EGIR-RISC Study Group","journal-title":"Diabetologia"},{"key":"2868_CR19","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214\u2013E23 (1979). https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214","journal-title":"Am. J. Physiol."},{"key":"2868_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2796.2012.02540.x","volume":"272","author":"J Vangipurapu","year":"2012","unstructured":"J. Vangipurapu, A. Stan\u010d\u00e1kov\u00e1, T. Kuulasmaa, P. Soininen, A.J. Kangas, M. Ala-Korpela, J. Kuusisto, M. Laakso, Association between liver insulin resistance and cardiovascular risk factors. J. Intern Med. 272, 402\u2013408 (2012). https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02540.x","journal-title":"J. Intern Med."},{"key":"2868_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u20139 (1985). https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"2868_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462\u201370 (1999). https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"key":"2868_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1463-1326.2012.01615.x","volume":"14","author":"LD Monti","year":"2012","unstructured":"L.D. Monti, E. Setola, P.C. Lucotti, M.M. Marrocco-Trischitta, M. Comola, E. Galluccio, A. Poggi, S. Mamm\u00ec, A.L. Catapano, G. Comi, R. Chiesa, E. Bosi, P.M. Piatti, Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes. Metab. 14, 893\u2013900 (2012). https:\/\/doi.org\/10.1111\/j.1463-1326.2012.01615.x","journal-title":"Diabetes Obes. Metab."},{"key":"2868_CR24","doi-asserted-by":"publisher","first-page":"E978","DOI":"10.1152\/ajpendo.00003.2008","volume":"294","author":"E Galluccio","year":"2008","unstructured":"E. Galluccio, P. Piatti, L. Citterio, P.C. Lucotti, E. Setola, L. Cassina et al. Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis. Am. J. Physiol. Endocrinol. Metab. 294, E978\u2013E86 (2008). https:\/\/doi.org\/10.1152\/ajpendo.00003.2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2868_CR25","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1161\/01.CIR.0000095272.67948.17","volume":"108","author":"P Piatti","year":"2003","unstructured":"P. Piatti, C. Di Mario, L.D. Monti, G. Fragasso, F. Sgura, A. Caumo et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 108, 2074\u201381 (2003). https:\/\/doi.org\/10.1161\/01.CIR.0000095272.67948.17","journal-title":"Circulation"},{"key":"2868_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11154-013-9271-7","volume":"15","author":"M Matsuda","year":"2014","unstructured":"M. Matsuda, I. Shimomura, Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Rev. Endocr. Metab. Disord. 15, 1\u201310 (2014). https:\/\/doi.org\/10.1007\/s11154-013-9271-7","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2868_CR27","doi-asserted-by":"publisher","first-page":"170532","DOI":"10.1155\/2013\/170532","volume":"2013","author":"Y Li","year":"2013","unstructured":"Y. Li, L. Ding, W. Hassan, D. Abdelkader, J. Shang, Adipokines and hepatic insulin resistance. J. Diabetes Res 2013, 170532 (2013). https:\/\/doi.org\/10.1155\/2013\/170532","journal-title":"J. Diabetes Res"},{"key":"2868_CR28","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1381\/096089206778392149","volume":"16","author":"A Baranova","year":"2006","unstructured":"A. Baranova, S.I. Gowder, K. Schlauch, H. Elariny, R. Collantes, A. Afendy, J.P. Ong, Z. Goodman, V. Chandhoke, Z.M. Younossi, Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes. Surg. 16, 1118\u20131125 (2006). https:\/\/doi.org\/10.1381\/096089206778392149","journal-title":"Obes. Surg."},{"key":"2868_CR29","doi-asserted-by":"publisher","first-page":"549748","DOI":"10.1155\/2012\/549748","volume":"2012","author":"N Vrachnis","year":"2012","unstructured":"N. Vrachnis, P. Belitsos, S. Sifakis, K. Dafopoulos, C. Siristatidis, K.I. Pappa, Z. Iliodromiti, Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J. Endocrinol. 2012, 549748 (2012). https:\/\/doi.org\/10.1155\/2012\/549748","journal-title":"Int J. Endocrinol."},{"key":"2868_CR30","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/hep.23116","volume":"50","author":"A Gastaldelli","year":"2009","unstructured":"A. Gastaldelli, S.A. Harrison, R. Belfort-Aguilar, L.J. Hardies, B. Balas, S. Schenker, K. Cusi, Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50, 1087\u201393 (2009). https:\/\/doi.org\/10.1002\/hep.23116","journal-title":"Hepatology"},{"key":"2868_CR31","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1016\/j.bbrc.2008.08.009","volume":"581","author":"H Oku","year":"2007","unstructured":"H. Oku, F. Matsuura, M. Koseki, J.C. Sandoval, M. Yuasa-Kawase, K. Tsubakio-Yamamoto, D. Masuda, N. Maeda, T. Ohama, M. Ishigami, M. Nishida, K. Hirano, S. Kihara, M. Hori, I. Shimomura, S. Yamashita, Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. Febs. Lett. 581, 5029\u20135033 (2007). https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.009","journal-title":"Febs. Lett."},{"key":"2868_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.bbrc.2007.05.040","volume":"358","author":"F Matsuura","year":"2007","unstructured":"F. Matsuura, H. Oku, M. Koseki, J.C. Sandoval, M. Yuasa-Kawase, K. Tsubakio-Yamamoto, D. Masuda, N. Maeda, K. Tsujii, M. Ishigami, M. Nishida, K. Hirano, S. Kihara, M. Hori, I. Shimomura, S. Yamashita, Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem. Biophys. Res. Commun. 358, 1091\u20131095 (2007). https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.040","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2868_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/01.atv.18.8.1335","volume":"18","author":"DL Rainwater","year":"1998","unstructured":"D.L. Rainwater, S.M. Haffner, Insulin and 2-hour glucose levels are inversely related to Lp (a) concentrations controlled for LPA genotype. Arterioscler Thromb. Vasc. Biol. 18, 1335\u20131341 (1998). https:\/\/doi.org\/10.1161\/01.atv.18.8.1335","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"2868_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/diacare.18.2.193","volume":"18","author":"SM Haffner","year":"1995","unstructured":"S.M. Haffner, P. Karhapaa, D.L. Rainwater, L. Mykkanen, G. Aldrete Jr, M. Laakso, Insulin sensitivity and Lp (a) concentrations in normoglycemic men. Diabetes Care 18, 193\u2013189 (1995). https:\/\/doi.org\/10.2337\/diacare.18.2.193","journal-title":"Diabetes Care"},{"key":"2868_CR35","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.33549\/physiolres.933583.","volume":"66","author":"H Vaverkov\u00e1","year":"2017","unstructured":"H. Vaverkov\u00e1, D. Kar\u00e1sek, M. Halenka, L. Cib\u00ed\u010dkov\u00e1, V. Kub\u00ed\u010dkov\u00e1, Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects. Physiol. Res 66, S113\u2013S120 (2017). https:\/\/doi.org\/10.33549\/physiolres.933583.","journal-title":"Physiol. Res"},{"issue":"4","key":"2868_CR36","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/jcp.26050","volume":"233","author":"G Ferretti","year":"2018","unstructured":"G. Ferretti, T. Bacchetti, T.P. Johnston, M. Banach, M. Pirro, A. Sahebkar, Lipoprotein(a): a missing culprit in the management of athero-thrombosis? J. Cell Physiol. 233(4), 2966\u201381 (2018). https:\/\/doi.org\/10.1002\/jcp.26050","journal-title":"J. Cell Physiol."},{"issue":"1-2","key":"2868_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.autneu.2009.02.003","volume":"148","author":"JP Fisher","year":"2009","unstructured":"J.P. Fisher, C.N. Young, P.J. Fadel, Central sympathetic overactivity: maladies and mechanisms. Auton. Neurosci. 148(1-2), 5\u201315 (2009). https:\/\/doi.org\/10.1016\/j.autneu.2009.02.003","journal-title":"Auton. Neurosci."},{"key":"2868_CR38","doi-asserted-by":"publisher","unstructured":"Lautt WW. Hepatic Circulation: Physiology and Pathophysiology. San Rafael (CA): Morgan & Claypool Life Sciences. 2009. Colloquium Series on Integrated Systems Physiology: From Molecule to Function to Disease. https:\/\/doi.org\/10.4199\/C00004ED1V01Y200910ISP001","DOI":"10.4199\/C00004ED1V01Y200910ISP001"},{"key":"2868_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1172\/JCI109714","volume":"65","author":"RA Rizza","year":"1980","unstructured":"R.A. Rizza, E. Cryer, Haymond, J.E. Gerich, Adrenergic mechanisms for effects of epinephrine on glucose production and clearance in man. J. Clin. Invest 65, 682\u2013689 (1980). https:\/\/doi.org\/10.1172\/JCI109714","journal-title":"J. Clin. Invest"},{"key":"2868_CR40","doi-asserted-by":"publisher","first-page":"E682","DOI":"10.1152\/ajpendo.00038.2002","volume":"283","author":"TKT Lam","year":"2002","unstructured":"T.K.T. Lam, H. Yoshii, C.A. Haber, E. Bogdanovic, L. Lam, I.G. Fantus, A. Giacca, Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am. J. Physiol. 283, E682\u2013E691 (2002). https:\/\/doi.org\/10.1152\/ajpendo.00038.2002","journal-title":"Am. J. Physiol."},{"key":"2868_CR41","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.3748\/wjg.v10.i21.3208","volume":"10","author":"L Li","year":"2004","unstructured":"L. Li, G.-Y. Yang, Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats. World J. Gastroenterol. 10, 3208\u20133211 (2004). https:\/\/doi.org\/10.3748\/wjg.v10.i21.3208","journal-title":"World J. Gastroenterol."},{"key":"2868_CR42","doi-asserted-by":"publisher","first-page":"S516","DOI":"10.1055\/s-2001-15114","volume":"109","author":"EW Kraegen","year":"2001","unstructured":"E.W. Kraegen, G.J. Cooney, J. Ye, A.L. Thompson, Triglycerides, fatty acids and insulin resistance\u2014hyperinsulinemia. Exp. Clin. Endocrinol. Diabetes 109, S516\u201326 (2001). https:\/\/doi.org\/10.1055\/s-2001-15114","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02868-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:41:32Z","timestamp":1643982092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02868-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02868-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}